Clinical trial
Spironolactone for Reducing Proteinuria in Diabetic Nephropathy
NCT00498537 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00498537 |
|---|---|
| Title | Spironolactone for Reducing Proteinuria in Diabetic Nephropathy |
| Official title | Spironolactone for Reducing Proteinuria in Diabetic Nephropathy |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Status | Completed |
| Study type | Interventional |
| Conditions | Diabetic Nephropathy |
| Intervention type | Drug |
| Interventions | spironolactone |
| Enrollment | 30 |
| Start date | Jan 1, 2003 |
| Primary completion | Dec 1, 2005 |
| Completion | Jun 1, 2006 |
| First posted | Jul 10, 2007 |
| Last update posted | Oct 17, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: